Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$50.07 - $66.05 $2.41 Million - $3.18 Million
-48,105 Closed
0 $0
Q2 2021

Jul 20, 2021

BUY
$56.61 - $80.46 $9,057 - $12,873
160 Added 0.33%
48,105 $3.03 Million
Q1 2021

May 06, 2021

BUY
$86.23 - $125.19 $100,026 - $145,220
1,160 Added 2.48%
47,945 $4.46 Million
Q4 2020

Jan 13, 2021

BUY
$79.17 - $111.47 $218,509 - $307,657
2,760 Added 6.27%
46,785 $4.19 Million
Q3 2020

Nov 06, 2020

BUY
$81.91 - $134.94 $299,381 - $493,205
3,655 Added 9.05%
44,025 $4.55 Million
Q2 2020

Jul 13, 2020

BUY
$54.33 - $89.52 $1.13 Million - $1.86 Million
20,830 Added 106.6%
40,370 $3.19 Million
Q1 2020

Apr 08, 2020

BUY
$49.34 - $68.76 $964,103 - $1.34 Million
19,540 New
19,540 $1.13 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $539M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Investment House LLC Portfolio

Follow Investment House LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.